Oppenheimer Trims Zimmer Biomet (NYSE:ZBH) Target Price to $145.00

Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective reduced by Oppenheimer from $155.00 to $145.00 in a research note released on Thursday morning, Benzinga reports. They currently have an outperform rating on the medical equipment provider’s stock. A number of other research analysts also recently commented on the stock. Truist Financial dropped their […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: BlackRock Innovation and Growth Term Trust (NYSE:BIGZ) Major Shareholder Acquires $583,125.85 in Stock
Next post The GEO Group (NYSE:GEO) Stock Rating Lowered by StockNews.com